Brief: Think Research Announces $12.8 Mln Of New Biopharma Contracts Signed During Q3 2022
20/09/2022 14:21
Sept 20 (Reuters) - Think Research Corporation THNK.V :
* THINK RESEARCH ANNOUNCES APPROXIMATELY $12.8 MILLION OF
NEW
BIOPHARMA CONTRACTS SIGNED DURING Q3 2022
* THINK RESEARCH ANNOUNCES APPROXIMATELY $12.8 MILLION OF
NEW
BIOPHARMA CONTRACTS SIGNED DURING Q3 2022
Source text for Eikon: ID:nPn8BR9Gja
Further company coverage: THNK.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Think Research
See all newsBrief: Think Research Announces Agreement For Subsequent Advance Under Existing Convertible Facility
Brief: Think Research Announces Agreement For Subsequent Advance Under Existing Convertible Facility
Canada Research Roundup: Bank of Montreal, Scotiabank, Transalta Renewables
Brief: Think Research Corporation Announces Record Second Quarter 2023 Results
Brief: Think Research Announces Bridge Loan